News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Enrique Grande: Can FDG-PET/CT Improve Lymph Node Detection in Variant Histology Bladder Cancer?
Enrique Grande/mdandersonhospiten.es
Jun 26, 2025, 06:13

Enrique Grande: Can FDG-PET/CT Improve Lymph Node Detection in Variant Histology Bladder Cancer?

Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared an article by Francesco Pio Bizzarri et al. on LinkedIn, adding

“Can FDG-PET/CT improve lymph node detection in variant histology Bladder Cancer?
This study compares PET/CT vs conventional CT/MRI for nodal staging in patients undergoing radical cystectomy.
Findings may support imaging decisions in VH subtypes.”

Title: Utility of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Detecting Lymph Node Involvement in Comparison to Conventional Imaging in Patients with Bladder Cancer with Variant Histology

Authors: Francesco Pio Bizzarri, Adam W. Nelson, Alexandra J. Colquhoun, Niyati Lobo

You can read the Full Article on European Urology Oncology

Enrique Grande: Can FDG-PET/CT Improve Lymph Node Detection in Variant Histology Bladder Cancer?

More posts featuring Enrique Grande.

Adam W. Nelson Alexandra J. Colquhoun bladder cancer cancer Enrique Grande FDG-PET/CT Francesco Pio Bizzarri Lymph Node Detection Niyati Lobo OncoDaily Oncology
Special Coverage
Blog
Jun 26, 2025, 13:31
Yan Leyfman: Ejaculation Frequency Linked to Lower Prostate Cancer Risk
Insight
Jun 26, 2025, 13:15
Celebrating Innovation, Impact and Empathy in Cancer Care - 2025 CancerX Accelerator Showcase Honored 3 Standout Startups
Blog
Jun 26, 2025, 12:40
Sami Mansfield: How I Help Bridge the Gap in Patient-centered Care - 3 Actionable Strategies for Oncology Teams
Oncolibrary
Jun 26, 2025, 12:32
MASCC 2025: Sarcopenia and CT Fat Metrics Show No Survival Impact in NSCLC
Blog
Jun 26, 2025, 12:13
Andrei Nikiforchin: Honored to Contribute to the New Guideline on Gastric Cancer with Peritoneal Metastases
Blog
Jun 26, 2025, 12:03
Paolo Tarantino: Get Free Registration for 24th IBC East Breast Oncology Conference using the code TARANTINO
Blog
Jun 26, 2025, 11:53
Sendurai Mani: A Week of Insight and Innovation at the Aspen Cancer Conference 2025
Opinion
Jun 26, 2025, 11:16
Elena Castro Discussed Positive Findings from the CAPTURE and AMPLITUDE trials in the ESMO Daily Reporter - ESMO
Blog
Jun 26, 2025, 11:14
Sumanta Pal: Had a Blast Chatting with Walter Stadler and Alan H Bryce at ASCO25 for the City of Hope Podcast
Blog
Jun 26, 2025, 10:44
How Can EU Cancer Policy Best Support Cyprus? - European Cancer Organisation
Insight
Jun 26, 2025, 10:37
Beth Faiman: Hot Off the Presses - NCCN Guidelines v1.2026 Now Online
Opinion
Jun 26, 2025, 10:26
Rahul Banerjee: One of the Most Eloquent Arguments About 2nd-line CAR-T in Multiple Myeloma I've Ever Seen